BioPharm.Si (Q3270309): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, bg, mt, pt, da, ro, sv, nl, fr, de, it, sl, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, bg, mt, pt, da, ro, sv,) |
(Set a claim value: summary (P836): Nova Geração de Drogas Biológicas) |
||||||||||||||
| (7 intermediate revisions by 2 users not shown) | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
| Property / beneficiary name (string): CO BIK / rank | |||||||||||||||
| Property / summary: New Generation of Biological Drugs (English) / qualifier | |||||||||||||||
readability score: 0.0468238864611248
| |||||||||||||||
| Property / summary | Property / summary | ||||||||||||||
Nova Geração de Drogas Biológicas (Portuguese) | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: Q296801 / rank | |||||||||||||||
| Property / intervention field | |||||||||||||||
| Property / intervention field: Technology transfer and university-enterprise cooperation primarily benefiting SMEs / rank | |||||||||||||||
| Property / intervention field | |||||||||||||||
| Property / intervention field: Cluster support and business networks primarily benefiting SMEs / rank | |||||||||||||||
| Property / intervention field | |||||||||||||||
| Property / intervention field: Research and innovation activities in public research centres and centres of competence including networking / rank | |||||||||||||||
| Property / intervention field | |||||||||||||||
| Property / intervention field: Research and innovation processes in SMEs (including voucher schemes, process, design, service and social innovation) / rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 4,777,897.3 Euro / rank | |||||||||||||||
| Property / budget | Property / budget | ||||||||||||||
| 8,810,160.0 Euro
| ||||||||||||||
| Property / co-financing rate | |||||||||||||||
| |||||||||||||||
| Property / co-financing rate: 80.0 percent / rank | |||||||||||||||
| Property / contained in Local Administrative Unit | |||||||||||||||
| Property / contained in Local Administrative Unit: Ajdovščina / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / coordinate location | |||||||||||||||
45°53'18.82"N, 13°54'17.50"E
| |||||||||||||||
| Property / coordinate location: 45°53'18.82"N, 13°54'17.50"E / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / location (string) | |||||||||||||||
Ajdovščina | |||||||||||||||
| Property / location (string): Ajdovščina / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / priority axis | |||||||||||||||
| Property / priority axis: International competitiveness of research, innovation and technological development in accordance with smart specialisation for greater competitiveness and greening of the economy / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / thematic objective | |||||||||||||||
| Property / thematic objective: Research and innovation / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / intervention field | |||||||||||||||
| Property / intervention field: Research and innovation activities in public research centres and centres of competence including networking / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / intervention field | |||||||||||||||
| Property / intervention field: Technology transfer and university-enterprise cooperation primarily benefiting SMEs / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / intervention field | |||||||||||||||
| Property / intervention field: Cluster support and business networks primarily benefiting SMEs / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: CO BIK / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
CO BIK | |||||||||||||||
| Property / beneficiary name (string): CO BIK / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / date of last update | |||||||||||||||
17 November 2023
| |||||||||||||||
| Property / date of last update: 17 November 2023 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 11:34, 9 October 2024
Project Q3270309 in Slovenia
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BioPharm.Si |
Project Q3270309 in Slovenia |
Statements
8,810,160.0 Euro
0 references
7 July 2016
0 references
31 December 2021
0 references
CO BIK
0 references
45°53'28.61"N, 13°53'57.23"E
0 references
45°53'18.82"N, 13°54'17.50"E
0 references
5270
0 references
Nova Generacija bioloških zdravil (Slovenian)
0 references
New Generation of Biological Drugs (English)
12 October 2021
0.0468238864611248
0 references
Ajdovščina
0 references
17 November 2023
0 references
Identifiers
OP20.00363
0 references